SCHEMBL3343096

SCHEMBL3343096

O=C(OC(=O)C(F)(F)F)c1ccc(-c2cccnc2Oc2ccc(Nc3ccccn3)cc2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3343093 0.87
SCHEMBL2487368 0.84
Trifluoroacetic Acid SCHEMBL3341960 0.80
SCHEMBL2485851 0.79
Trifluoroacetic Acid SCHEMBL3340577 0.79
SCHEMBL2485197 0.79
Trifluoroacetic Acid SCHEMBL3339809 0.79
Trifluoroacetic Acid SCHEMBL3346006 0.79
SCHEMBL2484861 0.78
Trifluoroacetic Acid SCHEMBL3343236 0.78 PDE10A (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637500-B2 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors AMGEN INC. (US) 2014-01-28 US disclosed
EP-2376455-B1 AMINOPYRIDINE AND CARBOXYPYRIDINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS AMGEN INC (US) 2012-11-14 EP disclosed
US-20100160280-A1 AMINOPYRIDINE AND CARBOXYPYRIDINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS AMGEN INC. (US) 2010-06-24 US disclosed